Inhibition of Neisseria catarrhalis NE-11 transformation.
D001426:Bacterial Proteins / Q000096:biosynthesis; D002473:Cell Wall / Q000187:drug effects / Q000378:metabolism; D002701:Chloramphenicol / Q000494:pharmacology*; D003523:Cycloserine / Q000494:pharmacology*; D004269:DNA, Bacterial / Q000096:biosynthesis; D004140:Dinitrophenols / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D009154:Mutation; D009343:Neisseria / Q000187:drug effects*; D010504:Periodic Acid / Q000494:pharmacology*; D012964:Sodium / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology; D014170:Transformation, Genetic / Q000187:drug effects*
D001426:Bacterial Proteins; D004269:DNA, Bacterial; D004140:Dinitrophenols; D010504:Periodic Acid; D002701:Chloramphenicol; D003523:Cycloserine; D012964:Sodium; D013307:Streptomycin